863886-38-8 Usage
Uses
Used in Pharmaceutical Industry:
1H-Pyrrole-2,5-dione, 1-[1,1'-biphenyl]-4-yl-3,4-bis[(2-hydroxyethyl)thio]is used as a potential pharmaceutical candidate for its possible antioxidant and anti-inflammatory properties due to the presence of thio groups. 1H-Pyrrole-2,5-dione, 1-[1,1'-biphenyl]-4-yl-3,4-bis[(2-hydroxyethyl)thio]-'s unique structure may offer new avenues for drug development, particularly in the treatment of inflammatory and oxidative stress-related conditions.
Used in Chemical Research:
1H-Pyrrole-2,5-dione, 1-[1,1'-biphenyl]-4-yl-3,4-bis[(2-hydroxyethyl)thio]serves as a subject of interest in chemical research, where its unique structure and potential biological activity can be further explored. Researchers may investigate its interactions with biological systems, its synthesis and modification, and its potential applications in various fields, including materials science and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 863886-38-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,8,8 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 863886-38:
(8*8)+(7*6)+(6*3)+(5*8)+(4*8)+(3*6)+(2*3)+(1*8)=228
228 % 10 = 8
So 863886-38-8 is a valid CAS Registry Number.
863886-38-8Relevant articles and documents
Development of antiproliferative phenylmaleimides that activate the unfolded protein response
Muus, Ulrike,Hose, Curtis,Yao, Wei,Kosakowska-Cholody, Teresa,Farnsworth, David,Dyba, Marzena,Lountos, George T.,Waugh, David S.,Monks, Anne,Burke Jr., Terrence R.,Michejda, Christopher J.
supporting information; experimental part, p. 4535 - 4541 (2010/08/22)
The current paper presents the synthesis and evaluation of a series of maleimides that were designed to inhibit the Cdc25 phosphatase by alkylation of catalytically essential cysteine residues. Although in HepB3 cell culture assays the analogues did exhib
Maleiimide anti-tumor phosphatase inhibitors
-
Page/Page column 13, (2008/06/13)
The present invention features maleiimide compounds, pharmaceutical compositions of maleiimide compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more maleiimide compounds of the inve
